Bayer will now seek approval for Kerendia in the non-diabetic CKD setting. Credit: sasirin pamai / Shutterstock.com. Bayer is looking to expand the use case of its non-steroidal chronic kidney disease ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results